Clinics in Dermatology
Volume 27, Issue 6, Supplement , Pages S48-S53, November 2009

An investigator-blind, randomized, 4-week, parallel-group, multicenter pilot study to compare the safety and efficacy of a nonsteroidal cream (Promiseb Topical Cream) and desonide cream 0.05% in the twice-daily treatment of mild to moderate seborrheic dermatitis of the face☆

Department of Dermatology, University of Alabama at Birmingham School of Medicine, Ste 414, 700 18th St S, Birmingham, AL 35233-3805, USA

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ Dr Elewski has received clinical grant funding from and is a consultant to Johnson & Johnson and Stiefel Laboratories, Inc. The clinical trial number for this study is PSC0801.

PII: S0738-081X(09)00192-8

doi:10.1016/j.clindermatol.2009.09.002

Clinics in Dermatology
Volume 27, Issue 6, Supplement , Pages S48-S53, November 2009

Article Tools

* Image Usage & Resolution